Literature DB >> 16137987

Corticotropin-releasing hormone during pregnancy is associated with infant temperament.

Elysia Poggi Davis1, Laura M Glynn, Christine Dunkel Schetter, Calvin Hobel, Aleksandra Chicz-Demet, Curt A Sandman.   

Abstract

During pregnancy corticotropin-releasing hormone (CRH) is released into maternal and fetal circulation from the placenta. Elevated concentrations of placental CRH are associated with spontaneous preterm birth, but the consequences for infant development, independent of birth outcome, are unknown. In this study, the effects of placental CRH on infant temperament were examined in a sample of 248 full-term infants. Maternal blood samples were collected at 19, 25 and 31 weeks of gestation for CRH analysis. Infant temperament was assessed with measures of fear and distress at 2 months of age. Infants of mothers with low CRH at 25 weeks of gestation scored lower in fear and distress at 2 months. CRH at 19 and 31 weeks' gestation was not significantly associated with measures of infant temperament, suggesting the possibility that there is a sensitive period for its effects. These data suggest that prenatal exposure to CRH may exert influences that persist into the postnatal period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137987     DOI: 10.1159/000086709

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  42 in total

1.  Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression.

Authors:  Jennifer Hahn-Holbrook; Christine Dunkel Schetter; Chander Arora; Calvin J Hobel
Journal:  Clin Psychol Sci       Date:  2013-07-01

Review 2.  Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus.

Authors:  Curt A Sandman; Elysia P Davis; Claudia Buss; Laura M Glynn
Journal:  Neuroendocrinology       Date:  2011-04-15       Impact factor: 4.914

Review 3.  Fetal exposure to placental corticotropin-releasing hormone (pCRH) programs developmental trajectories.

Authors:  Curt A Sandman
Journal:  Peptides       Date:  2015-04-01       Impact factor: 3.750

Review 4.  Prenatal stress and enhanced developmental plasticity.

Authors:  Sarah Hartman; Jay Belsky
Journal:  J Neural Transm (Vienna)       Date:  2018-09-11       Impact factor: 3.575

5.  Is there a viability-vulnerability tradeoff? Sex differences in fetal programming.

Authors:  Curt A Sandman; Laura M Glynn; Elysia Poggi Davis
Journal:  J Psychosom Res       Date:  2013-08-05       Impact factor: 3.006

6.  Pregnancy anxiety in expectant mothers predicts offspring negative affect: The moderating role of acculturation.

Authors:  Nicole E Mahrer; Isabel F Ramos; Christine Guardino; Elysia Poggi Davis; Sharon L Ramey; Madeleine Shalowitz; Christine Dunkel Schetter
Journal:  Early Hum Dev       Date:  2019-11-24       Impact factor: 2.079

7.  Intergenerational Effect of Maternal Exposure to Childhood Maltreatment on Newborn Brain Anatomy.

Authors:  Nora K Moog; Sonja Entringer; Jerod M Rasmussen; Martin Styner; John H Gilmore; Norbert Kathmann; Christine M Heim; Pathik D Wadhwa; Claudia Buss
Journal:  Biol Psychiatry       Date:  2017-07-21       Impact factor: 13.382

8.  Prenatal beta-endorphin as an early predictor of postpartum depressive symptoms in euthymic women.

Authors:  Ilona S Yim; Laura M Glynn; Christine Dunkel Schetter; Calvin J Hobel; Aleksandra Chicz-Demet; Curt A Sandman
Journal:  J Affect Disord       Date:  2010-01-03       Impact factor: 4.839

9.  Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy.

Authors:  Ilona S Yim; Laura M Glynn; Christine Dunkel-Schetter; Calvin J Hobel; Aleksandra Chicz-DeMet; Curt A Sandman
Journal:  Arch Gen Psychiatry       Date:  2009-02

Review 10.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.